Skip to content

Clinical trials

Phase 2/3 Hepatitis C trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2/3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20111
20133
20152
20161
20171
20191
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
University of Texas Southwestern Medical Center2
White River Junction Veterans Affairs Medical Center2
Centers for Disease Control and Prevention1
Icahn School of Medicine at Mount Sinai1
National Institute on Drug Abuse (NIDA)1
Ohio State University1
Rhode Island Hospital1
Timothy Morgan, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C13
HIV Infections2
Hepatitis C, Chronic2
Stress Disorders, Post-Traumatic2
Acquired Immunodeficiency Syndrome1
Cryoglobulinemia1
Fibrosis1
Hepatitis1
Liver Diseases1
Major Depressive Disorder1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.